(JREM) JPMorgan s (Ireland) ICAV - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BF4G6Z54
JREM: Emerging Markets, ESG, Equity, Diversification, UCITS, ETF, Exposure
Objective: The JPMorgan ETFs (Ireland) ICAV - Global Emerging Markets Research Enhanced Index Eq (ESG) UCITS ETF USD Acc (Ticker: JREM) is designed to provide exposure to emerging markets equities with an ESG focus. Listed on XETRA, this ETF tracks the Morningstar EM TME NR USD index, offering a diversified portfolio of emerging market stocks. The fund is structured as an Irish ICAV and distributes dividends in USD accumulation shares.
3-Month Forecast: Based on
Additional Details: As part of the Global Emerging Markets Equity category, JREM provides access to a broad range of emerging market equities, focusing on companies that meet ESG criteria. The funds ESG framework aims to enhance returns while aligning with sustainable investing principles. The Morningstar EM TME NR USD index serves as the benchmark, ensuring the ETF reflects the performance of its target market. JREM is incorporated in Ireland and is denominated in USD, making it accessible to international investors seeking emerging market exposure with a focus on sustainability.
Additional Sources for JREM ETF
JREM ETF Overview
Market Cap in USD | 1,410m |
Category | Global Emerging Markets Equity |
IPO / Inception | 2018-12-05 |
JREM ETF Ratings
Growth Rating | 20.5 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -18.2 |
Analysts | - |
Fair Price Momentum | 25.92 EUR |
Fair Price DCF | - |
JREM Dividends
Currently no dividends paidJREM Growth Ratios
Growth Correlation 3m | -12.3% |
Growth Correlation 12m | 41.1% |
Growth Correlation 5y | 7.1% |
CAGR 5y | 5.08% |
CAGR/Max DD 5y | 0.18 |
Sharpe Ratio 12m | 0.50 |
Alpha | -2.58 |
Beta | 0.618 |
Volatility | 14.22% |
Current Volume | 2.9k |
Average Volume 20d | 6k |
As of June 01, 2025, the stock is trading at EUR 29.15 with a total of 2,887 shares traded.
Over the past week, the price has changed by -1.59%, over one month by +4.82%, over three months by -5.45% and over the past year by +5.64%.
Neither. Based on ValueRay´s Analyses, JPMorgan s (Ireland) ICAV is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 20.53 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of JREM is around 25.92 EUR . This means that JREM is currently overvalued and has a potential downside of -11.08%.
JPMorgan s (Ireland) ICAV has no consensus analysts rating.
According to our own proprietary Forecast Model, JREM JPMorgan s (Ireland) ICAV will be worth about 29.4 in June 2026. The stock is currently trading at 29.15. This means that the stock has a potential upside of +0.75%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 29.4 | 0.8% |